Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts

Figure 3 Astragaloside IV inhibited the proliferation-promoting capacity of gastric cancer-associated fibroblasts. Conditioned media were prepared from the GCAFs treated by vehicle control, 10 μmol/L astragaloside IV, 20 μmol/L astragaloside IV or 40 μmol/L astragaloside IV, and used to culture BGC-823 cells. After culture for 48 h, the proliferation capacity of the BGC-823 cells was measured. Data are plotted as mean ± SD of three separate experiments. ^aP < 0.05 and ^bP < 0.01 vs the BGC-823 cells cultured with the conditioned medium from control-treated GCAFs.